Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer

Jude Khatib, Radhika Kainthla

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences